Insilico Medicine has been nominated for the 2026 Prix Galien USA “Best Start-Up” Award in the Biotechnology category, marking the second consecutive year that the clinical-stage biotechnology company has received recognition from one of the life sciences industry’s most prominent innovation programs. The nomination comes as generative artificial intelligence moves from experimental research laboratories into […]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.